Andriamainty F, Filípek J, Kovács P, Balgavý P
Faculty of Pharmacy, J. A. Comenius University, Bratislava, Slovak Republic.
Pharmazie. 1996 Apr;51(4):242-5.
Local anesthetic [2-(alkyloxy)phenyl]-2-(1-piperidinyl)ethyl esters of carbamic acid modulate the activity of the purified sarcoplasmic reticulum (Ca-Mg)ATPase. The phase of insensitivity or slight stimulation of the activity at lower anesthetics concentrations is followed by the inhibition phase at higher concentrations. The potency to inhibit the activity at high concentrations is maximal for the homologue with the hexyloxy substituent and decreases for shorter and longer substituents. The inhibition of activity can be partially reversed by addition of n-decane. The inhibition could be caused by the binding of anesthetics to binding sites at the protein--lipid bilayer interface. The changed thickness of the hydrophobic part of this interface might be responsible for the n-decane reversible inhibition and its dependence on the alkyloxy substituent chain length, while the changed structure of the polar part of this interface could be the cause of the n-decane irreversible inhibiton.
局部麻醉剂[2-(烷氧基)phenyl]-2-(1-哌啶基)乙基酯类对纯化的肌浆网(Ca-Mg)ATP酶的活性有调节作用。在较低麻醉剂浓度下,该酶活性出现不敏感或轻微刺激阶段,随后在较高浓度时进入抑制阶段。在高浓度下抑制活性的效力,对于具有己氧基取代基的同系物最大,对于较短和较长取代基则降低。通过添加正癸烷,活性抑制可部分逆转。这种抑制可能是由于麻醉剂与蛋白质-脂质双层界面的结合位点结合所致。该界面疏水部分厚度的改变可能是正癸烷可逆抑制及其对烷氧基取代基链长依赖性的原因,而该界面极性部分结构的改变可能是正癸烷不可逆抑制的原因。